271 related articles for article (PubMed ID: 25673443)
1. Efficacy and safety of Tripterygium wilfordii hook F versus acitretin in moderate to severe psoriasis vulgaris: a randomized clinical trial.
Wu C; Jin HZ; Shu D; Li F; He CX; Qiao J; Yu XL; Zhang Y; He YB; Liu TJ
Chin Med J (Engl); 2015 Feb; 128(4):443-9. PubMed ID: 25673443
[TBL] [Abstract][Full Text] [Related]
2. Plasma miR-126 expression correlates with risk and severity of psoriasis and its high level at baseline predicts worse response to Tripterygium wilfordii Hook F in combination with acitretin.
Duan Y; Zou J; Mao J; Guo D; Wu M; Xu N; Zhou J; Zhang Y; Guo W; Jin W
Biomed Pharmacother; 2019 Jul; 115():108761. PubMed ID: 31100542
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.
Lv QW; Zhang W; Shi Q; Zheng WJ; Li X; Chen H; Wu QJ; Jiang WL; Li HB; Gong L; Wei W; Liu H; Liu AJ; Jin HT; Wang JX; Liu XM; Li ZB; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin YF; Fei YY; Su JM; Zhao LD; Jiang Y; Li J; Tang FL; Zhang FC; Lipsky PE; Zhang X
Ann Rheum Dis; 2015 Jun; 74(6):1078-86. PubMed ID: 24733191
[TBL] [Abstract][Full Text] [Related]
4. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center.
Yang L; Wang Q; Hou Y; Zhao J; Li M; Xu D; Zeng X
Clin Rheumatol; 2020 Mar; 39(3):813-821. PubMed ID: 31713733
[TBL] [Abstract][Full Text] [Related]
5. Effect of cream, prepared with Tripterygium wilfordii Hook F and other four medicinals, on joint pain and swelling in patients with rheumatoid arthritis: a double-blinded, randomized, placebo controlled clinical trial.
Jiao J; Tang X; Gong X; Yin H; Jiang Q; Wei C
J Tradit Chin Med; 2019 Feb; 39(1):89-96. PubMed ID: 32186028
[TBL] [Abstract][Full Text] [Related]
6. Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.
Jiang M; Zha Q; Zhang C; Lu C; Yan X; Zhu W; Liu W; Tu S; Hou L; Wang C; Zhang W; Liang Q; Fan B; Yu J; Zhang W; Liu X; Yang J; He X; Li L; Niu X; Liu Y; Guo H; He B; Zhang G; Bian Z; Lu A
Sci Rep; 2015 Apr; 5():9700. PubMed ID: 26814847
[TBL] [Abstract][Full Text] [Related]
7. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
Dogra S; Jain A; Kanwar AJ
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
[TBL] [Abstract][Full Text] [Related]
9. Role of keratinocytes and immune cells in the anti-inflammatory effects of Tripterygium wilfordii Hook. f. in a murine model of psoriasis.
Ru Y; Li H; Zhang R; Luo Y; Song J; Kuai L; Xing M; Hong S; Sun X; Ding X; Lu Y; Liu L; Na C; Zhou Y; Li B; Li X
Phytomedicine; 2020 Oct; 77():153299. PubMed ID: 32823074
[TBL] [Abstract][Full Text] [Related]
10. Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial.
Wang L; Gong L; Zhang X; Cao Y; Long P; Zhang W; Zeng X; Li C
Clin Rheumatol; 2021 Jun; 40(6):2427-2438. PubMed ID: 33389313
[TBL] [Abstract][Full Text] [Related]
11. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
[TBL] [Abstract][Full Text] [Related]
12.
Wang Y; Tian Z; Huang S; Dang N
Drug Des Devel Ther; 2023; 17():3767-3781. PubMed ID: 38144417
[TBL] [Abstract][Full Text] [Related]
13. Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial.
Zhu W; Li Y; Gong J; Zuo L; Zhang W; Cao L; Gu L; Guo Z; Li N; Li J
Dig Liver Dis; 2015 Jan; 47(1):14-9. PubMed ID: 25445405
[TBL] [Abstract][Full Text] [Related]
14. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
Goldbach-Mansky R; Wilson M; Fleischmann R; Olsen N; Silverfield J; Kempf P; Kivitz A; Sherrer Y; Pucino F; Csako G; Costello R; Pham TH; Snyder C; van der Heijde D; Tao X; Wesley R; Lipsky PE
Ann Intern Med; 2009 Aug; 151(4):229-40, W49-51. PubMed ID: 19687490
[TBL] [Abstract][Full Text] [Related]
16. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
[TBL] [Abstract][Full Text] [Related]
17. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.
Liu L; Zhao H; Sun X; Zheng Q; Luo Y; Ru Y; Zhang Y; Chen X; Zhu B; Yin C; Li B; Li X
BMC Complement Altern Med; 2018 Aug; 18(1):243. PubMed ID: 30170584
[TBL] [Abstract][Full Text] [Related]
19. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
20. Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety.
Li T; Xie J; Li Y; Routy JP; Li Y; Han Y; Qiu Z; Lv W; Song X; Sun M; Zhang X; Wang F; Jiang H
HIV Clin Trials; 2015; 16(2):49-56. PubMed ID: 25874991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]